Literature DB >> 15013972

Comparison of benchtop microplate beta counters with the traditional gamma counting method for measurement of chromium-51 release in cytotoxic assays.

Dora Wallace1, Allan Hildesheim, Ligia A Pinto.   

Abstract

The most traditional method used to measure the lytic activity of cytotoxic T lymphocytes or natural killer (NK) cells is the chromium release assay (CRA). No study has been reported that systematically compares the traditional gamma counting method with various benchtop microplate scintillation formats to measure chromium release. Here we investigated the utilization of microplate beta counters in comparison with the traditional gamma counting method to quantitate antigen-specific cytolysis, lymphokine-activated killer (LAK) activity, and NK activity in the CRA. Supernatants from standard CRA (n = 7) were directly transferred to a 96-well microplate containing either a solid scintillant (Lumaplate) or a liquid scintillant (flexible beta plate). Samples were quantified by using two benchtop microplate beta counters, Wallac Microbeta Trilux (Lumalux and Trilux methods, respectively) and Packard TopCount instruments (TopCount method). These results were then compared with data from an identical assay run in parallel using the traditional gamma counting method (LKB). The lytic activity for influenza virus-stimulated effectors measured in the benchtop microplate beta counters using Lumalux and Trilux methods exhibited excellent correlations with the one measured in the traditional LKB (r = 0.967 and 0.968, respectively). The TopCount method demonstrated a similar correlation (r = 0.966). Similar findings were observed for LAK and NK activity. The 96-well microplate format, specifically the dry-scintillant Lumaplates, offers several advantages over the traditional gamma counting format. Most notable are the reductions in sample volume needed and in the total sample preparation and counting time. Furthermore, this system reduces the amount of dry and mixed radioactive waste generated while using the same instrument for gamma- and beta-emitting isotopes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15013972      PMCID: PMC371223          DOI: 10.1128/cdli.11.2.255-260.2004

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  13 in total

1.  Lymphocyte proliferation and cytotoxic assays using flat-bed scintillation counting.

Authors:  C G Potter; F Gotch; G T Warner; J Oestrup
Journal:  J Immunol Methods       Date:  1987-12-24       Impact factor: 2.303

2.  Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs.

Authors:  K T Brunner; J Mauel; J C Cerottini; B Chapuis
Journal:  Immunology       Date:  1968-02       Impact factor: 7.397

3.  51Cr-release assay adapted to a 96-well format sample reading.

Authors:  G G Hillman; N Roessler; R S Fulbright; J E Pontes; G P Haas
Journal:  Biotechniques       Date:  1993-10       Impact factor: 1.993

4.  Alloantigenic stimulation bypasses CD28-B7 costimulatory blockade by an interleukin-2-dependent mechanism.

Authors:  V Blazevic; L A Pinto; C M Trubey; G M Shearer
Journal:  J Leukoc Biol       Date:  2000-06       Impact factor: 4.962

5.  In vitro immunologic and virologic effects of interleukin 15 on peripheral blood mononuclear cells from normal donors and human immunodeficiency virus type 1-infected patients.

Authors:  D R Lucey; L A Pinto; F R Bethke; J Rusnak; G P Melcher; F N Hashemi; A L Landay; H A Kessler; R J Paxton; K Grabstein; G M Shearer
Journal:  Clin Diagn Lab Immunol       Date:  1997-01

6.  Development of a novel flow cytometric cell-mediated cytotoxicity assay using the fluorophores PKH-26 and TO-PRO-3 iodide.

Authors:  A E Lee-MacAry; E L Ross; D Davies; R Laylor; J Honeychurch; M J Glennie; D Snary; R W Wilkinson
Journal:  J Immunol Methods       Date:  2001-06-01       Impact factor: 2.303

7.  T cell response to human papillomavirus 16 E7 in mice: comparison of Cr release assay, intracellular IFN-gamma production, ELISPOT and tetramer staining.

Authors:  Nico Michel; Peter Ohlschläger; Wolfram Osen; Eva-Jasmin Freyschmidt; Heidrun Guthöhrlein; Andreas M Kaufmann; Martin Müller; Lutz Gissmann
Journal:  Intervirology       Date:  2002       Impact factor: 1.763

Review 8.  Beyond 51Cr release: New methods for assessing HIV-1-specific CD8+ T cell responses in peripheral blood and mucosal tissues.

Authors:  B L Shacklett
Journal:  Clin Exp Immunol       Date:  2002-11       Impact factor: 4.330

9.  ENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids.

Authors:  L A Pinto; J Sullivan; J A Berzofsky; M Clerici; H A Kessler; A L Landay; G M Shearer
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

Review 10.  Cancer immunotherapy with natural killer cells.

Authors:  Ronald B Herberman
Journal:  Semin Oncol       Date:  2002-06       Impact factor: 4.929

View more
  2 in total

Review 1.  Advances in FIV vaccine technology.

Authors:  Elizabeth W Uhl; Marcus Martin; James K Coleman; Janet K Yamamoto
Journal:  Vet Immunol Immunopathol       Date:  2008-01-20       Impact factor: 2.046

2.  Axons are injured by antigen-specific CD8(+) T cells through a MHC class I- and granzyme B-dependent mechanism.

Authors:  Brian M Sauer; William F Schmalstieg; Charles L Howe
Journal:  Neurobiol Dis       Date:  2013-07-27       Impact factor: 5.996

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.